Acetylcholine (ACh) was one of the first neurotransmitters ... novel agents that target defined nervous-system pathologies and receptor subtypes. General anaesthetics are small hydrophobic ...

In particular, the finding that acetylcholine-receptor antagonists have an antiproliferative effect on neural stem cells has important implications for the understanding and treatment of Alzheimer ...

Those who suffer myasthenia gravis experience muscle weakness that can affect the muscles we use to blink, smile and move our ...

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

Epysqli is used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia ...

Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver ...

Scopolamine acts: i) as a competitive inhibitor at postganglionic muscarinic receptor sites of the parasympathetic nervous system, and ii) on smooth muscles that respond to acetylcholine but lack ...